Browsing Tag
Australia
639 posts
Stantec lifts 2026 margin outlook as adjusted EBITDA jumps 17% to C$333m
Stantec’s backlog hit a record C$9.2 billion as Q2 revenue and margins climbed. See how Page and Water demand are shaping 2026 growth.
How Inpex turned a 22.8% oil volume drop into a record ¥510bn profit year
Inpex lifts 2026 net profit forecast to record ¥510 billion, launches ¥140bn buyback and eyes mid-2027 Abadi LNG FID as Ichthys covers Hormuz shock.
James Hardie Industries plc (ASX: JHX) jumps 6% as FY27 outlook rises
James Hardie raised FY27 guidance after a strong Q1. The bigger test is whether AZEK growth can turn into cash and rapidly reduce debt.
Pacific nations split over China missile test as New Zealand pushes joint response in Suva
Pacific Island foreign ministers are debating whether to issue a collective response to China’s submarine-launched ballistic missile test, exposing divisions over Beijing’s growing military presence and the region’s promise to remain an “Ocean of Peace.”
Glencore targets ASX secondary listing as surging earnings revive its copper and M&A ambitions
Glencore plans an Australian Securities Exchange secondary listing by October 2026 after first-half adjusted EBITDA surged 86%, giving Australian investors direct access to its copper, coal and commodity-trading portfolio.
Adisyn (ASX: AI1) shares surge after graphene scale-up to 200mm wafer, but commercial proof still lies ahead
Adisyn has expanded its low-temperature graphene deposition process from a 1cm² coupon to an industry-standard 200mm wafer, accelerating the path towards semiconductor partnerships while leaving repeatability, device performance and customer qualification as the decisive tests.
SciDev (ASX: SDV) shares jump as first data centre contracts validate water growth strategy
SciDev has secured its first revenue-generating data centre contracts in Australia, giving investors early evidence that its water recycling strategy can move from presentation slides to paying customers.
Steadfast Group (ASX: SDF) rises as A$6 bid reaches August test
Steadfast trades 14% below its A$6 proposal. A binding deal or August 26 earnings will decide whether the ASX: SDF gap can close.
Avecho Biotechnology (ASX: AVE) secures Japanese patent for CBD capsule as global licensing strategy expands
Avecho Biotechnology’s Japanese patent adds another major jurisdiction to the intellectual property estate surrounding its TPM-enhanced cannabidiol capsule. The grant strengthens the company’s negotiating position, but clinical completion, regulatory approval and regional licensing remain the decisive commercial tests.
Megaport (ASX: MP1) slips as August 20 results test A$827m AI bet
Megaport’s A$4.2bn value rests on an A$827m AI bet. August 20 results must prove its core network can fund the transformation.